| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,304,000 | 1,244,000 | 1,146,000 | 1,286,000 | | Cost of Revenue | 1,038,000 | 996,000 | 946,000 | 1,177,000 | | | Gross Profit | 266,000 | 248,000 | 200,000 | 109,000 | | | Operating Expenses | | Research Development | 18,000 | 18,000 | 20,000 | 21,000 | | Selling General and Administrative | 110,000 | 94,000 | 134,000 | 124,000 | | Non Recurring | 50,000 | 27,000 | 4,000 | 94,000 | | Others | 20,000 | 21,000 | 17,000 | 18,000 | | | | Total Operating Expenses | 198,000 | 160,000 | 175,000 | 257,000 | | | | Operating Income or Loss | 68,000 | 88,000 | 25,000 | (148,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 13,000 | 61,000 | 12,000 | 23,000 | | Earnings Before Interest And Taxes | 100,000 | 176,000 | 35,000 | (117,000) | | Interest Expense | 51,000 | 54,000 | 51,000 | 66,000 | | Income Before Tax | 49,000 | 122,000 | (16,000) | (183,000) | | Income Tax Expense | (350,000) | 17,000 | 5,000 | (43,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 399,000 | 105,000 | (21,000) | (140,000) | | | Non-recurring Events | | Discontinued Operations |
-
| (1,000) | 1,000 | (15,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 399,000 | 104,000 | (20,000) | (155,000) | | Preferred Stock And Other Adjustments | (3,000) | (2,000) | (3,000) | (2,000) | | | Net Income Applicable To Common Shares | $396,000 | $102,000 | ($23,000) | ($157,000) |
|
0.22% Nasdaq 
0.51 (1.62%) 
Income Statement
